Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ari B. Cuperfain, Gali Katznelson, Tianna Costa, Patrick Wong, Narges Beyraghi, Tony P. George, Michelle R. Lofwall & Nitin Chopra. (2023) Factors to guide the use of extended-release buprenorphine formulations for specific patient populations. Journal of Substance Use 0:0, pages 1-7.
Read now
Read now
Howard Hassman, Stephanie Strafford, Sunita N. Shinde, Amy Heath, Brent Boyett & Robert L. Dobbins. (2023) Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection. The American Journal of Drug and Alcohol Abuse 49:1, pages 43-52.
Read now
Read now
Articles from other publishers (2)
Sophia Little, Bethany White, Maja Moensted, Kerryn Butler, Mark Howard, Jillian Roberts & Adrian Dunlop. (2023) Health and correctional staff acceptability of depot buprenorphine in NSW prisons. International Journal of Drug Policy 114, pages 103978.
Crossref
Crossref
Michael Soyka. (2021) Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review. Frontiers in Pharmacology 12.
Crossref
Crossref